| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |